Showing results (411-420 of 99,750) with videos related to
Sort By:
Pageof 9,975
Autonomic & Autacoid Pharmacology|September 4, 2008
Expression of the endogenous, nicotinic acetylcholine receptor ligand, SLURP-1, in human colon cancerA Pettersson, S Nordlander, G Nylund, et al.Nano Letters|January 26, 2021
All-Optically Reconfigurable Plasmonic Metagrating for Ultrafast Diffraction ManagementAndrea Schirato, Andrea Mazzanti, Remo Proietti Zaccaria, et al.European Journal of Haematology|April 17, 2015
Decreased invasive fungal disease but no impact on overall survival by posaconazole compared to fluconazole prophylaxis: a retrospective cohort study in patients receiving induction therapy for acute myeloid leukaemia/myelodysplastic syndromesTorsten Dahlén, Mats Kalin, Kerstin Cederlund, et al.ACS Applied Materials & Interfaces|March 10, 2025
Theoretical Insights into Dual-Atom Catalysts for Bifunctional Oxygen Catalysis at a Constant Electrode PotentialMengmeng Shao, Yangfan ShaoScientific Reports|November 13, 2025
Impact of COVID-19 restrictions on childhood allergic sensitization: a three-phase comparative studyWenxia Shao, Qingyi ShaoNano Letters|May 9, 2017
Balancing Near-Field Enhancement, Absorption, and Scattering for Effective Antenna-Reactor Plasmonic PhotocatalysisKun Li, Nathaniel J Hogan, Matthew J Kale, et al.Cardiovascular Research|January 1, 1996
Coronary venous drug infusion in the ischaemic-reperfused isolated rat heartY Uriuda, Q D Wang, X S Li, et al.Journal of Cardiovascular Pharmacology|June 1, 1995
Beneficial effects of H290/51, a new lipid peroxidation inhibitor, on functional recovery after ischemia and reperfusion in isolated cold-arrested rat heartsQ D Wang, Y Uriuda, X S Li, et al.Nano Letters|October 13, 2005
Plasmons in the metallic nanoparticle-film system as a tunable impurity problemF Le, N Z Lwin, J M Steele, et al.Journal of Cardiovascular Pharmacology and Therapeutics|October 24, 2006
Ventricular fibrillation induced by ischemia-reperfusion is not prevented by the NPY Y2 receptor antagonist BIIE0246Arnfinn Ilebekk, Morten Eriksen, Knut Sevre, et al.Pageof 9,975